News - Licensing


Current filters:


Popular Filters

951 to 962 of 962 results

Actelion to appeal final jury verdict in Asahi Kasei litigation in US Court


Switzerland-based Actelion (SIX: ATLN) today commented on the verdict issued with regard to Japan’s…

ActelionAsahi KaseiBiotechnologyCardio-vascularCoTherixfasudilLegalLicensing

Karo Bio and Alkem Labs collaborate to develop eprotirome


Sweden’s Karo Bio AB (STO KARO) and Indian drugmaker Alkem Laboratories have entered into a collaboration…

Alkem LaboratoriesAsia-PacificCardio-vasculareprotiromeKaro BioLicensingPharmaceuticalResearchRest of the World

Vivalis acquires single-cell antibody from SC World


French drug firm Vivalis (Euronext: VLS) says it has acquired high-throughput screening (HTS) single-cell…

Asia-PacificLicensingPharmaceuticalSC WorldVivalis

Pfizer views China opportunities, signing MoU with Shanghai Pharma


Global drugs behemoth Pfizer (NYSE: PFE) has signed a memorandum of understanding (MOU) with Shanghai…

Asia-PacificLicensingPfizerPharmaceuticalPrevenarShanghai Pharmaceutical Group

Forest Labs FY 4th-qtr beats forecasts; in-licenses antiarrhythmic


US drugmaker Forest Laboratories (NYSE: FRX) reported that, for its fiscal fourth quarter ended March…

azimilideCardio-vascularFinancialForest LaboratoriesLicensingPharmaceutical

Gilead in-licenses MicroDose Therapeutx’ MDT-637 for RSV; posts 1st-qtr results


Gilead Sciences (Nasdaq: GILD) and MicroDose Therapeutx have entered into an exclusive worldwide license…

FinancialGilead SciencesLicensingMicroDose TherapeutxPharmaceuticalResearchRespiratory and Pulmonary

ARIAD in three exclusive out-licensing deals for ARGENT cell-signaling regulation technology


USA-based ARIAD Pharmaceuticals (Nasdaq: ARIA) has announced execution of three exclusive out-license…

Ariad PharmaceuticalsLicensingPharmaceuticalResearch

Active Biotech and Ipsen in broad partnership for TASQ in uro-oncology


Sweden’s Active Biotech AB (NORDIC: ACTI) and Paris, France-based Ipsen (Euronext: IPN) have entered…

Active BiotechBiotechnologyIpsenLicensingOncologyPharmaceuticalResearchtasquinimod

Alapis enters MoU with China's CSPC Pharma on areas of collaboration


Greek drugmaker Alapis SA (APSHF: PK) has signed a memorandum of understanding (MoU) with one of China's…

AlapisCSPC PharmaceuticalGenericsLicensing

951 to 962 of 962 results

Back to top